According to the World Health Organization, chronic illness and disease are the leading causes of death worldwide – and they're on the rise. But nobody is talking about what's behind most of these chronic illnesses – mold and mycotoxins (small toxins produced by fungi present in our food and homes). If you have an underlying issue with mycotoxins, then your chronic illness may be treatable and reversible. In this Episode of Spectrum of Health, Dr. Eric Gordon and Dr. Nafysa Parpia talk with Dr. Schaffner about the importance of detoxification therapies during mycotoxin and complex chronic illness treatment. They also discuss keeping an open mind to the diversity of diagnosing and treating complex chronic illnesses. Dr. Nafysa Parpia has spent the last decade treating patients with complex chronic illnesses from all over the US and the world. Her specialization is patients with tick-borne disease, mold/mycotoxin illness, environmentally acquired condition, autoimmunity, fibromyalgia, and ME/CFS (Chronic Fatigue Syndrome). Modalities she uses include a synergistic blend of regenerative medicine, oral and intravenous micronutrient therapies, peptide therapies, botanical medicine, pharmaceuticals, injection therapies, functional nutrition, and lifestyle counseling. Dr. Parpia sees patients at Gordon Medical in the San Francisco Bay Area. She is on ISEAI's Board of Directors (International Society for Environmentally Acquired Illness) and is a Scientific and Medical Advisor for Neurohacker Collective. She received her Doctorate of Naturopathic Medicine from Bastyr University and her Bachelor of Science from the University of British Columbia. Eric D. Gordon, MD, President of Gordon Medical Research Center (GMRC), is the founder and owner of Gordon Medical Associates (GMA) in the San Francisco Bay area, specializing in complex chronic illness. In addition to clinical practice (40+ years), Dr. Gordon is engaged in clinical research. Combining forces with Dr. Robert Naviaux and his research into metabolomics, mitochondrial function, and chronic inflammatory disease is now bringing this dream to life. In 2016 Dr. Gordon was co-author with Dr. Naviaux on a groundbreaking study, "Metabolic Features of Chronic Fatigue Syndrome," published in the Proceedings of the National Academy of Science (PNAS).

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related